Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

Trial Identifier: TDR16536
Sponsor: Sanofi
Collaborator:
Denali Therapeutics Inc.
Start Date: December 2018
Primary Completion Date: June 2020
Study Completion Date: June 2020
Condition: Amyotrophic lateral sclerosis (ALS)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Netherlands, South Holland Leiden, South Holland, Netherlands, 2333
United States, Florida Orlando, Florida, United States, 32806
United States, Utah Salt Lake City, Utah, United States, 84124